At PCI we recognise that biologically derived therapeutic products are the new frontier, heralding revolutionary treatments of a number of diseases and injuries.
These therapies traditionally have widely varying temperature requirements and maintaining a robust Cold Chain process is critical to the integrity of the products.
Through the acquisition of Biotec Services International, PCI provides pharmaceutical service solutions for a range of therapies including gene therapies, somatic cell therapies (stem cells) and tissue engineered products also known as Advanced Therapeutic Medicinal Products (ATMPs).
With over 10 years of experience with such products, PCI will assist you with innovative solutions to overcome the specific challenges associated with the storage, labeling and delivery
at cryogenic temperatures to -196oC. This experience combined with our proven track record of working with dry ice and dry nitrogen shipping systems ensures that we are able to offer a full ATMP service. PCI is committed to remaining abreast of the latest advances in shipping technology.
Our Technical Support Team is dedicated to testing and validating the newest technologies ensuring that we utilize the most economic yet most effective and reliable shipping methods supported by our exceptional track record in temperature controlled shipments.